The Perma-Flow coronary bypass graft (Possis Medical, Inc, Minneapolis
, MN) currently is undergoing expanded clinical trial. From November 1
992 through June 1994 we have used this artificial conduit in 8 patien
ts without autologous alternatives. These eases allowed the establishm
ent of a technical basis for successful implantation of this graft. Al
l studied coronary anastomoses are patent.